Search Results 3531-3540 of 26401 for oral

  1. Ryan J. Solinsky, M.D. - Doctors and Medical Staff - Mayo Clinic

    Best Oral Presentation AwardInternational Autonomic Symposium, Vancouver, BC, CAN. 2017. Post-doctoral Fellow- Best Research AwardKessler Institute for ...

  2. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

  3. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) - Mayo Clinic

    glucocorticoids (A short course of oral prednisone [≤ 14 days] is allowed) 8. History of active or chronic liver disease 9. Chronic or acute renal disorder

  4. The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach - Mayo Clinic

    Nasal or oral inflammation, defined as the development of painful or painless oral ulcers or purulent or bloody nasal discharge. B. Abnormal chest ...

  5. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Oral glutamine;; Proton pump inhibitors;; Diuretics;; Systemic antibiotics or antibiotics affecting the gastrointestinal tract;; Oral rehydration fluids.

  6. Hematology - Clinical trials

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

  7. Hair loss - Doctors and departments - Mayo Clinic

    ... Oral lichen planus, Blue rubber bleb nevus syndrome, Burning mouth syndrome, Diffuse capillary malformation with overgrowth, Canker sores, Scarring alopecia ...

  8. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

    This is a phase 3, randomized, controlled, open-label, multicenter study of the oral formulation of dexamethasone plus IXAZOMIB compared with treatment ...

  9. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

    Oral inhibitors of Janus-associated kinase (JAK), Bruton's tyrosine kinase (BTK), or tyrosine kinase 2 (TYK2), including baricitinib, tofacitinib ...

  10. Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation - Mayo Clinic

    All women of childbearing potential will use an appropriate contraceptive method, including barrier method, oral contraceptive medication, contraceptive device ...